TelyRx Holdings Inc. is seeing a significant rise in its stock price, reflecting growing investor optimism.
Today, TelyRx Holdings Inc. (TELY.TO) gained 4.67%, closing at CA$2.69. This uptick follows impressive revenue growth reported in recent financial results, likely boosting investor confidence.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$68.34M
52W high
$4.25
52W low
$2.00
1W change
-1.15%
Analyst Price Targets
Based on analyst covering TELY · as of Sep 17, 2026
Wall Street analysts forecast TELY stock price to rise 133.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+133.5% Upside
Current Price
C$2.57
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
55.9%
Annualized
90-Day Vol
88.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$2.15
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.42 | C$2.00 – C$2.94 |
| 60 trading days | C$2.28 | C$1.74 – C$3.00 |
| 90 trading days | C$2.15 | C$1.54 – C$3.00 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors may see TelyRx's recent financial performance as a strong sign of future growth potential, which is contributing to today’s positive stock movement.
TelyRx's Stock Up by 4.67% Today
With a market cap of CA$68.34 million, TelyRx's stock performance indicates increasing interest in its business model and financial health.
Bull case
The company recently reported significant revenue increases, with Q1 2026 revenues at $19.4 million, up from $6.9 million in Q1 2025. This kind of growth can attract more investors and improve market sentiment.
Bear case
Despite the positive movement, TelyRx's profit margin remains negative at -19.36%. This raises concerns about the company's ability to achieve profitability soon, which could dampen enthusiasm among investors.
Advertisement
Recent Financial Performance
TelyRx has shown remarkable growth in its revenue figures. For Q1 2026, the company achieved $19.4 million in revenue, a significant increase from $6.9 million in the same quarter last year. This upward trend is likely contributing to the stock's rise today.
Market Sentiment and Future Outlook
The positive movement in TelyRx's stock price reflects growing confidence among investors, especially as the company continues to demonstrate its ability to increase revenues. However, the negative profit margin still raises questions about long-term sustainability.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
